ATPS-97 TEMOZOLOMIDE RESISTANT GLIOBLASTOMA (GBM) CELLS AND XENOGRAFTS ARE ESPECIALLY SENSITIVE TO PARP-INHIBITION

類似資料

• ATPS-50 REVISITING CARBOPLATIN AS A THERAPY FOR GLIOBLASTOMA (GBM)
  著者:: Liao, Jenny, 等
  出版事項: (2015)
• ABT-888 restores sensitivity in temozolomide resistant glioma cells and xenografts
  著者:: Yuan, Alice L., 等
  出版事項: (2018)
• DRES-06. PREVENTING THE EMERGENCE OF TEMOZOLOMIDE RESISTANCE IN GLIOBLASTOMA BY PARP-1 INHIBITION
  著者:: Yuan, Alice, 等
  出版事項: (2018)
• MTR-08 MODELING TMZ RESISTANCE IN PATIENT-DERIVED BRAIN TUMOR- INITIATING CELLS
  著者:: Lun, Xueqing, 等
  出版事項: (2015)
• Efficacy of protracted temozolomide dosing is limited in MGMT unmethylated GBM xenograft models
  著者:: Cen, Ling, 等
  出版事項: (2013)